COVID-19

News

Pair of R&D updates bolster GSK ahead of investor meeting

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares

News

US aims $80m of its rescue plan funding at public health IT

President Joe Biden's $3 billion pandemic rescue package includes $80 million in funding for to strengthen the US's public health IT and data science capabilities.

News

NHS app downloads spike after COVID jab status update

The NHS App has soared in popularity since it was updated in May to allow people to record their COVID-19 vaccination status, with more than 2 million new signups taking the total number of

News

EU and AZ both claim victory in COVID jab supply lawsuit

A court in Belgium has ordered AstraZeneca to deliver additional doses of its COVID-19 vaccine to EU member states by 27 September, although far fewer than the amount sought by the European

News

White House pledges $3 billion war chest for COVID antiviral...

The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development of a new generation of antiviral therapies for COVID-19, as well as future viral

News

CureVac hit hard as its COVID jab fails to make the grade

CureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its mRNA-based COVID-19 vaccine was just 47% effective in its 40,000-subject phase 3 t

Pair of R&D updates bolster GSK ahead of investor meeting

US aims $80m of its rescue plan funding at public health IT

NHS app downloads spike after COVID jab status update

EU and AZ both claim victory in COVID jab supply lawsuit

White House pledges $3 billion war chest for COVID antiviral...

CureVac hit hard as its COVID jab fails to make the grade

Recordati gets €10.9bn takeover bid from private equity firm

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks